Westlaw Journal Pharmaceutical published “2018 Year-End Roundup of Federal Circuit Obviousness Decisions in Biopharma,” authored by Axinn partner Jonathan Harris and associates Drew Hillier and Nisan Zaghi*.

Click here to access the article. 

*At the time of this writing, Nisan Zaghi's admission to the New York bar is pending.